lawrence panasci
Segal Cancer Centre
Montreal, Canada
Associate Editor
Pharmacology of Anti-Cancer Drugs
Segal Cancer Centre
Montreal, Canada
Associate Editor
Pharmacology of Anti-Cancer Drugs
Magna Græcia University
Catanzaro, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
The University of Queensland
Brisbane, Australia
Associate Editor
Pharmacology of Anti-Cancer Drugs
INSERM U1232 Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA)
Nantes, France
Associate Editor
Pharmacology of Anti-Cancer Drugs
INSERM U1232 Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA)
Nantes, France
Associate Editor
Pharmacology of Anti-Cancer Drugs
Amgen (United States)
Thousand Oaks, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Brighton and Sussex Medical School
Brighton, United Kingdom
Associate Editor
Pharmacology of Anti-Cancer Drugs
Amsterdam University Medical Centers
Amsterdam, Netherlands
Associate Editor
Pharmacology of Anti-Cancer Drugs
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Switzerland
Associate Editor
Pharmacology of Anti-Cancer Drugs
INSERM U1037 Centre de Recherche en Cancérologie de Toulouse
Toulouse, France
Associate Editor
Pharmacology of Anti-Cancer Drugs
Temple University
Philadelphia, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, University of Barcelona
Barcelona, Spain
Associate Editor
Pharmacology of Anti-Cancer Drugs
Institute of Basic Medicine and Cancer, Chinese Academy of Sciences (CAS)
Hangzhou, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Pisa
Pisa, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of South Dakota
Vermillion, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Oncology, School of Medicine, University of Turin
Torino, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs